These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12065608)

  • 1. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.
    Camarero J; Sanchez V; O'Shea E; Green AR; Colado MI
    J Neurochem; 2002 Jun; 81(5):961-72. PubMed ID: 12065608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
    Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
    Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism.
    Colado MI; O'Shea E; Esteban B; Granados R; Green AR
    Neuropharmacology; 1999 Feb; 38(2):307-14. PubMed ID: 10218873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
    Colado MI; O'Shea E; Granados R; Murray TK; Green AR
    Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
    Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum.
    Shankaran M; Yamamoto BK; Gudelsky GA
    J Neurochem; 1999 Jun; 72(6):2516-22. PubMed ID: 10349862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF; Brodkin J
    J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders.
    Peraile I; Granado N; Torres E; Gutiérrez-López MD; Moratalla R; Colado MI; O'Shea E
    Psychopharmacology (Berl); 2013 Nov; 230(1):125-35. PubMed ID: 23681166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.
    Colado MI; O'Shea E; Granados R; Esteban B; Martín AB; Green AR
    Br J Pharmacol; 1999 Feb; 126(4):911-24. PubMed ID: 10193771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Eur J Pharmacol; 1999 Dec; 385(2-3):103-10. PubMed ID: 10607865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
    Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
    J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice.
    Barros-Miñones L; Goñi-Allo B; Suquia V; Beitia G; Aguirre N; Puerta E
    Neuropharmacology; 2015 Jun; 93():124-33. PubMed ID: 25666033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Peterson AL; Gilman TL; Banks ML; Sprague JE
    Synapse; 2006 Apr; 59(5):317-9. PubMed ID: 16421905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
    Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
    Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
    Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA induced dopamine release in vivo: role of endogenous serotonin.
    Koch S; Galloway MP
    J Neural Transm (Vienna); 1997; 104(2-3):135-46. PubMed ID: 9203077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
    Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
    Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
    Nair SG; Gudelsky GA
    Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.